Equities analysts expect Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) to announce sales of $118.65 million for the current quarter, according to Zacks. Three analysts have made estimates for Sabra Healthcare REIT’s earnings, with the lowest sales estimate coming in at $105.20 million and the highest estimate coming in at $145.25 million. Sabra Healthcare REIT posted sales of $61.93 million in the same quarter last year, which suggests a positive year over year growth rate of 91.6%. The business is expected to announce its next quarterly earnings report on Wednesday, November 1st.

On average, analysts expect that Sabra Healthcare REIT will report full year sales of $118.65 million for the current financial year, with estimates ranging from $371.81 million to $422.57 million. For the next financial year, analysts anticipate that the firm will report sales of $610.72 million per share, with estimates ranging from $594.20 million to $628.84 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Sabra Healthcare REIT.

Several equities analysts have recently issued reports on SBRA shares. Zacks Investment Research raised shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $24.00 price target for the company in a report on Tuesday, August 29th. Mizuho reissued a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th. Cantor Fitzgerald reissued a “buy” rating and set a $30.00 price target on shares of Sabra Healthcare REIT in a report on Friday, September 8th. JMP Securities raised shares of Sabra Healthcare REIT from a “market perform” rating to an “outperform” rating and set a $23.00 price target for the company in a report on Tuesday, September 5th. Finally, BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. Sabra Healthcare REIT has an average rating of “Hold” and a consensus target price of $25.00.

TRADEMARK VIOLATION WARNING: This report was first published by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2017/09/22/analysts-expect-sabra-healthcare-reit-inc-sbra-will-announce-quarterly-sales-of-118-65-million.html.

Shares of Sabra Healthcare REIT (NASDAQ SBRA) opened at 22.18 on Friday. Sabra Healthcare REIT has a 1-year low of $19.30 and a 1-year high of $29.10.

A number of hedge funds have recently bought and sold shares of SBRA. Bank of Montreal Can lifted its holdings in Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after purchasing an additional 1,191 shares during the period. Great West Life Assurance Co. Can lifted its holdings in Sabra Healthcare REIT by 6.6% in the first quarter. Great West Life Assurance Co. Can now owns 93,954 shares of the real estate investment trust’s stock worth $2,621,000 after purchasing an additional 5,841 shares during the period. Bank of New York Mellon Corp lifted its holdings in Sabra Healthcare REIT by 1.9% in the first quarter. Bank of New York Mellon Corp now owns 1,267,663 shares of the real estate investment trust’s stock worth $35,405,000 after purchasing an additional 23,747 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in Sabra Healthcare REIT by 9.6% in the first quarter. BNP Paribas Arbitrage SA now owns 37,139 shares of the real estate investment trust’s stock worth $1,037,000 after purchasing an additional 3,262 shares during the period. Finally, Comerica Bank lifted its holdings in Sabra Healthcare REIT by 4.0% in the first quarter. Comerica Bank now owns 72,146 shares of the real estate investment trust’s stock worth $2,061,000 after purchasing an additional 2,790 shares during the period. 99.26% of the stock is owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get a free copy of the Zacks research report on Sabra Healthcare REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.